{"protocolSection": {"identificationModule": {"nctId": "NCT00807989", "orgStudyIdInfo": {"id": "109887"}, "organization": {"fullName": "Yonsei University", "class": "OTHER"}, "briefTitle": "The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy", "officialTitle": "An Open Label, Randomized, Multicenter Clinical Trial to Compare the Efficacy and Safety of Lamotrigine / Valproate Coadministration and Carbamazepine as Initial Pharmacotherapy in Epilepsies (Phase \u2163)"}, "statusModule": {"statusVerifiedDate": "2015-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-03"}, "primaryCompletionDateStruct": {"date": "2012-05", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-05", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-11-28", "studyFirstSubmitQcDate": "2008-12-12", "studyFirstPostDateStruct": {"date": "2008-12-15", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-01-20", "resultsFirstSubmitQcDate": "2015-05-11", "resultsFirstPostDateStruct": {"date": "2015-05-29", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-06-29", "lastUpdatePostDateStruct": {"date": "2015-07-27", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Yonsei University", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "To evaluate the efficacy of usual monotherapy and low dose combination of Lamotrigine and Valproate. Low dose combination may be more effective and tolerable because they are low dose and VPA reduce Lamotrigine metabolism.", "detailedDescription": "An Open label, Randomized, Multicenter Clinical Trial to Compare the Efficacy and Safety of Lamotrigine / Valproate Coadministration and Carbamazepine as Initial Pharmacotherapy in Epilepsies"}, "conditionsModule": {"conditions": ["Epilepsy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 207, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Carbamazepine", "type": "ACTIVE_COMPARATOR", "description": "Carbamazepine", "interventionNames": ["Drug: Carbamazepine"]}, {"label": "Lamotrigine/Valproate", "type": "EXPERIMENTAL", "description": "Lamotrigine and Valproate combination therapy", "interventionNames": ["Drug: Lamotrigine/Valproate"]}], "interventions": [{"type": "DRUG", "name": "Carbamazepine", "armGroupLabels": ["Carbamazepine"]}, {"type": "DRUG", "name": "Lamotrigine/Valproate", "armGroupLabels": ["Lamotrigine/Valproate"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Retention Rate After 52 Weeks Maintenance Period", "description": "\\* Retention rate means completion rate (CR), the proportion of patients who have completed the 60-week study as planned.", "timeFrame": "52 weeks"}], "secondaryOutcomes": [{"measure": "Seizure Free Rate for 24 Weeks at Initial Target Dose", "timeFrame": "24 weeks"}, {"measure": "Seizure Free Rate for 52 Weeks at Initial Target Dose", "timeFrame": "52 weeks"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226516yr old\n* Who are diagnosed as epilepsy definitely\n* Who have minimum 2 unprovoked seizures and minimum 1 seizure in previous 3 months\n* Who need AED therapy and no AED medication for previous 1 year (exclude emergency medication for less than 2weeks)\n* Who is not pregnant\n* Who can report seizure diary by him/herself or caregiver\n* Who agree to this trial and provide informed consent.\n* Type of seizures : of generalized tonic-clonic, complex partial, and/or simple partial motor seizures;\n\nExclusion Criteria:\n\n* Who has progressive CNS disease.\n* Has serious systemic or psychiatric disease\n* Who is not suitable by investigator(uncooperative)\n* Who can not fill up diary check card\n* Is pregnant, breastfeeding, or planning to become pregnant\n* Exclusion - absence s. juvenile myoclonic epilepsy, atonic seizure, alcohol or other substance abusers, mental retardation etc.\n* Who cancels to agree to this trial and provide informed consent.\n* ALT, AST, bilirubin and BUN/Cr levels are more than twice normal range of them\n* WBC value is 2000 and less, Hb value is 9.0 and less, platelet count is 100,000 and less in CBC\n* Who took investigation products before participating this study", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "16 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Byung-In Lee", "affiliation": "Yonsei Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Kyoung Heo", "affiliation": "Yonsei Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sang-Kun Lee", "affiliation": "Seoul National Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sang-Ahm Lee", "affiliation": "Ulsan Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Dong-Jin Shin", "affiliation": "Gacheon Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Hong-Ki Song", "affiliation": "Hallym Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Young-In Kim", "affiliation": "Catholic Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Se-Jin Lee", "affiliation": "Youngnam Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sang-Ho Kim", "affiliation": "Donga Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Myung-Gyu Kim", "affiliation": "Cheonnam Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Yo-Sik Kim", "affiliation": "Wonkwang Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sang-Do Lee", "affiliation": "Dongsan Hosp.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sung-Eun Kim", "affiliation": "Pusan-Bak Hosp.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Sung-Pa Park", "affiliation": "Kyungbuk Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Joo-Yong Kim", "affiliation": "Hanrim Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Ok-Jun Kim", "affiliation": "Bundang Cha", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Soon-Ki Noh", "affiliation": "Bong-Sang Hosp.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Hyang-Woon Lee", "affiliation": "I-wha Univ.", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Jae-Moon Kim", "affiliation": "Chungnam Univ.", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Yonsei Medical Center", "city": "Seoul", "zip": "120-752", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Carbamazepine", "description": "Carbamazepine 100mg/day for the first two weeks. At next two weeks, dose of Carbamazepine was increased to 200mg/day in two divided doses"}, {"id": "FG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine 25mg/day for the first two weeks. At next two weeks, LTG 50 mg once a day"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "107"}, {"groupId": "FG001", "numSubjects": "100"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "104"}, {"groupId": "FG001", "numSubjects": "98"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Carbamazepine", "description": "Carbamazepine\n\nCarbamazepine"}, {"id": "BG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine/Valproate"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "104"}, {"groupId": "BG001", "value": "98"}, {"groupId": "BG002", "value": "202"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Year", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "33.2", "spread": "14.6"}, {"groupId": "BG001", "value": "36.5", "spread": "13.7"}, {"groupId": "BG002", "value": "34.8", "spread": "14.2"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "51"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "99"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "53"}, {"groupId": "BG001", "value": "50"}, {"groupId": "BG002", "value": "103"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Korea, Republic of", "categories": [{"measurements": [{"groupId": "BG000", "value": "104"}, {"groupId": "BG001", "value": "98"}, {"groupId": "BG002", "value": "202"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Retention Rate After 52 Weeks Maintenance Period", "description": "\\* Retention rate means completion rate (CR), the proportion of patients who have completed the 60-week study as planned.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "Carbamazepine", "description": "Carbamazepine\n\nCarbamazepine"}, {"id": "OG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine/Valproate"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "104"}, {"groupId": "OG001", "value": "98"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "104"}, {"groupId": "OG001", "value": "98"}]}]}]}, {"type": "SECONDARY", "title": "Seizure Free Rate for 24 Weeks at Initial Target Dose", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "24 weeks", "groups": [{"id": "OG000", "title": "Carbamazepine", "description": "Carbamazepine\n\nCarbamazepine"}, {"id": "OG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine/Valproate"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "90"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "51"}, {"groupId": "OG001", "value": "59"}]}]}]}, {"type": "SECONDARY", "title": "Seizure Free Rate for 52 Weeks at Initial Target Dose", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "52 weeks", "groups": [{"id": "OG000", "title": "Carbamazepine", "description": "Carbamazepine\n\nCarbamazepine"}, {"id": "OG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine/Valproate"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "90"}, {"groupId": "OG001", "value": "78"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "50"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "52 weeks", "eventGroups": [{"id": "EG000", "title": "Carbamazepine", "description": "Carbamazepine\n\nCarbamazepine", "seriousNumAffected": 9, "seriousNumAtRisk": 104, "otherNumAffected": 60, "otherNumAtRisk": 104}, {"id": "EG001", "title": "Lamotrigine/Valproate", "description": "Lamotrigine and Valproate combination therapy\n\nLamotrigine/Valproate", "seriousNumAffected": 0, "seriousNumAtRisk": 98, "otherNumAffected": 59, "otherNumAtRisk": 98}], "seriousEvents": [{"term": "Meningoencephalitis herpetic", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Alcoholic seizure", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Atonic seizures", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Joint dislocation", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Facet joint syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Abnormal behaviour", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Skin rash", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}, {"term": "Hospitalisation", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 98}]}], "otherEvents": [{"term": "Headache", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 29, "numAffected": 26, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 52, "numAffected": 26, "numAtRisk": 98}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 23, "numAffected": 18, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 18, "numAffected": 17, "numAtRisk": 98}]}, {"term": "Somnolence", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 14, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 12, "numAffected": 12, "numAtRisk": 98}]}, {"term": "Memory impairment", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 14, "numAffected": 10, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 98}]}, {"term": "Tremor", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 11, "numAffected": 11, "numAtRisk": 98}]}, {"term": "Skin rash", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 98}]}, {"term": "Dyspepsia", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 7, "numAffected": 5, "numAtRisk": 98}]}, {"term": "Weight gain", "organSystem": "Metabolism and nutrition disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 9, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 98}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 7, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 26, "numAffected": 10, "numAtRisk": 98}]}, {"term": "Fatigue", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 104}, {"groupId": "EG001", "numEvents": 5, "numAffected": 4, "numAtRisk": 98}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "GT60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Dr. Yoon", "organization": "Yonsei University Severance Hospital", "email": "BILEE@yuhs.ac"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000004827", "term": "Epilepsy"}], "ancestors": [{"id": "D000001927", "term": "Brain Diseases"}, {"id": "D000002493", "term": "Central Nervous System Diseases"}, {"id": "D000009422", "term": "Nervous System Diseases"}], "browseLeaves": [{"id": "M7983", "name": "Epilepsy", "asFound": "Epilepsy", "relevance": "HIGH"}, {"id": "M5204", "name": "Brain Diseases", "relevance": "LOW"}, {"id": "M5742", "name": "Central Nervous System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC10", "name": "Nervous System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000077213", "term": "Lamotrigine"}, {"id": "D000002220", "term": "Carbamazepine"}, {"id": "D000014635", "term": "Valproic Acid"}], "ancestors": [{"id": "D000000927", "term": "Anticonvulsants"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000014150", "term": "Antipsychotic Agents"}, {"id": "D000014149", "term": "Tranquilizing Agents"}, {"id": "D000002492", "term": "Central Nervous System Depressants"}, {"id": "D000011619", "term": "Psychotropic Drugs"}, {"id": "D000026941", "term": "Sodium Channel Blockers"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000018682", "term": "GABA Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000018692", "term": "Antimanic Agents"}, {"id": "D000018712", "term": "Analgesics, Non-Narcotic"}, {"id": "D000000700", "term": "Analgesics"}, {"id": "D000018689", "term": "Sensory System Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000065701", "term": "Cytochrome P-450 CYP3A Inducers"}, {"id": "D000065693", "term": "Cytochrome P-450 Enzyme Inducers"}], "browseLeaves": [{"id": "M17383", "name": "Valproic Acid", "asFound": "Occupational therapy", "relevance": "HIGH"}, {"id": "M5480", "name": "Carbamazepine", "asFound": "Lymph node dissection", "relevance": "HIGH"}, {"id": "M1701", "name": "Lamotrigine", "asFound": "Muscle strength", "relevance": "HIGH"}, {"id": "M4246", "name": "Anticonvulsants", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M16904", "name": "Antipsychotic Agents", "relevance": "LOW"}, {"id": "M14474", "name": "Psychotropic Drugs", "relevance": "LOW"}, {"id": "M23177", "name": "Sodium Channel Blockers", "relevance": "LOW"}, {"id": "M30025", "name": "Diuretics, Potassium Sparing", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M4032", "name": "Analgesics", "relevance": "LOW"}, {"id": "M20786", "name": "Analgesics, Non-Narcotic", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AntiConv", "name": "Anticonvulsants"}, {"abbrev": "CNSDep", "name": "Central Nervous System Depressants"}, {"abbrev": "PsychDr", "name": "Psychotropic Drugs"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "Analg", "name": "Analgesics"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}]}}, "hasResults": true}